Microglial activation facilitates Aβ plaque removal following intracranial anti-Aβ antibody administration

Wilcock, Donna M, Munireddy, Sanjay K, Rosenthal, Arnon, Ugen, Kenneth E, Gordon, Marcia N, Morgan, Dave·2004·Neurobiology of Disease
DOI 10.1016/j.nbd.2003.09.015

Cited by (202)

Items 101–200 of 202

  1. Comparing the efficacy and neuroinflammatory potential of three anti-abeta antibodies
    James P. Fuller, Jeffrey B. Stavenhagen, Søren Christensen, Fredrik Kartberg, Martin J. Glennie, Jessica L. Teeling · 2015 · Acta Neuropathologica
  2. Lithium Treatment of APPSwDI/NOS2−/− Mice Leads to Reduced Hyperphosphorylated Tau, Increased Amyloid Deposition and Altered Inflammatory Phenotype
    Tiffany L. Sudduth, Joan G. Wilson, Angela L. Everhart, Carol A. Colton, Donna M. Wilcock · 2012 · PLoS ONE
  3. Vascular mTOR-dependent mechanisms linking the control of aging to Alzheimer's disease
    Verónica Galván, Matthew J. Hart · 2015 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
  4. Intracellular Amyloid β-Protein As a Therapeutic Target for Treating Alzheimers Disease
    Yasumasa Ohyagi · 2008 · Current Alzheimer Research
  5. Interaction of Alzheimer’s Aβ Peptide with an Engineered Binding Protein—Thermodynamics and Kinetics of Coupled Folding–Binding
    Wolfgang Hoyer, Torleif Härd · 2008 · Journal of Molecular Biology
  6. Microglia degrade Alzheimer’s amyloid-beta deposits extracellularly via digestive exophagy
    Jacquet, Rudy G., González Ibáñez, Fernando, Picard, Katherine, Funes, Lucy, Khakpour, Mohammadparsa, Gouras, Gunnar K., Tremblay, Marie-Ève, Maxfield, Frederick R., Solé-Domènech, Santiago · 2024 · Cell Reports
  7. Novel approaches for immunotherapeutic intervention in Alzheimer's disease
    Vitaly Vasilevko, David H. Cribbs · 2006 · Neurochemistry International
  8. Anti-Amyloid-β Single-Chain Antibody Brain Delivery Via AAV Reduces Amyloid Load But May Increase Cerebral Hemorrhages in an Alzheimer's Disease Mouse Model
    Jinghong Kou, Hong-Duck Kim, Abhinandan Pattanayak, Min Song, Jeong-Eun Lim, Hiroaki Taguchi, Sudhir Paul, John R. Cirrito, Selvarangan Ponnazhagan, Ken-ichiro Fukuchi · 2011 · Journal of Alzheimer s Disease
  9. Determination of Spatial and Temporal Distribution of Microglia by 230nm-High-Resolution, High-Throughput Automated Analysis Reveals Different Amyloid Plaque Populations in an APP/PS1 Mouse Model of Alzheimers Disease
    Katja Scheffler, Jan Stenzel, Markus Krohn, Cathleen Lange, Jacqueline Hofrichter, Toni Schumacher, Thomas Brüning, Anne-Sophie Plath, Lary C. Walker, Jens Pahnke · 2011 · Current Alzheimer Research
  10. Targeting Beta-Amyloid at the CSF: A New Therapeutic Strategy in Alzheimer’s Disease
    Manuel Menéndez‐González, Huber Padilla-Zambrano, Gabriel Alvarez, Estibaliz Capetillo‐Zarate, Cristina Tomás‐Zapico, Adriana Duarte Dalla Costa · 2018 · Frontiers in Aging Neuroscience
  11. The F(ab′)2 fragment of an Aβ-specific monoclonal antibody reduces Aβ deposits in the brain
    Yuichi Tamura, Kenji Hamajima, Kiyohiko Matsui, Shunsuke Yanoma, Masato Narita, NobuyoshiI Tajima, Ke-Qin Xin, Dennis M. Klinman, Kenji Okuda · 2005 · Neurobiology of Disease
  12. Mannan-Abeta28conjugate prevents Abeta-plaque deposition, but increases microhemorrhages in the brains of vaccinated Tg2576 (APPsw) mice
    Irina Petrushina, Anahit Ghochikyan, Mikayel Mkrtichyan, Grigor Mamikonyan, Nina Movsesyan, Rodmehr Ajdari, Vitaly Vasilevko, Adrine Karapetyan, Andrew Lees, Michael G. Agadjanyan et al. · 2008 · Journal of Neuroinflammation
  13. Microglial phagocytosis in Alzheimer disease
    Brown, Guy C., St George-Hyslop, Peter, Paolicelli, Rosa C., Lemke, Greg · 2026 · Nature Reviews Neurology
  14. Complex regulation of acute and chronic neuroinflammatory responses in mouse models deficient for nuclear factor kappa B p50 subunit
    Taisia Rõlova, Lakshman Puli, Johanna M. Magga, Hiramani Dhungana, Katja M. Kanninen, Sara Wojciehowski, Antero Salminen, Heikki Tanila, Jari Koıstınaho, Tarja Malm · 2013 · Neurobiology of Disease
  15. Immunotherapy for Alzheimer's Disease: Current Scenario and Future Perspectives
    M.B. Usman, Shanu Bhardwaj, Shatabhisha Roychoudhury, Dhruv Kumar, Athanasios T. Alexiou, Pravir Kumar, Rashmi K. Ambasta, Parteek Prasher, Shakti Dhar Shukla, Vijay Jagdish Upadhye et al. · 2021 · The Journal of Prevention of Alzheimer s Disease
  16. Production of monocytic cells from bone marrow stem cells: therapeutic usage in Alzheimer’s disease
    Johanna M. Magga, Ekaterina Savchenko, Tarja Malm, Taisia Rõlova, Eveliina Pollari, Piia K. Valonen, Šárka Lehtonen, Esa Jantunen, Jussi Aarnio, Petri P Lehenkari et al. · 2011 · Journal of Cellular and Molecular Medicine
  17. Transgenic potato expressing Aβ reduce Aβ burden in Alzheimer's disease mouse model
    Jung Won Youm, Hee Yeon Kim, Jee Hye Lo Han, Chang Hwan Jang, Hee Jin Ha, Inhee Mook‐Jung, Jae Heung Jeon, Cheol Yong Choi, Young Ho Kim, Hyun Soon Kim et al. · 2005 · FEBS Letters
  18. Role of inflammation in the neurobiology of stem cells
    Alain R. Simard, Serge Rivest · 2004 · Neuroreport
  19. Innate immunity in Alzheimer’s disease: the relevance of animal models?
    Diana Franco-Bocanegra, James A. R. Nicoll, Delphine Boche · 2017 · Journal of Neural Transmission
  20. Role of Glial Immunity in Lifespan Determination: A Drosophila Perspective
    Ilias Kounatidis, Stanislava Chtarbanova · 2018 · Frontiers in Immunology
  21. Chronic Verubecestat Treatment Suppresses Amyloid Accumulation in Advanced Aged Tg2576-AβPPswe Mice Without Inducing Microhemorrhage
    Stephanie A. Villarreal, Fuqiang Zhao, Lynn A. Hyde, Daniel Holder, Thomas W. Forest, Marie Sondey, Xia Chen, Cyrille Sur, Eric M. Parker, Matthew E Kennedy · 2017 · Journal of Alzheimer s Disease
  22. Immunotherapy in Alzheimer's Disease: Where Do We Stand? Where Should We Go?
    Rommy von Bernhardi M. · 2010 · Journal of Alzheimer s Disease
  23. Genomic characterization of Alzheimer’s disease and genotype-related phenotypic analysis of biological markers in dementia
    Ramón Cacabelos · 2004 · Pharmacogenomics
  24. Preventive immunization of aged and juvenile non-human primates to beta-amyloid
    Julia Kofler, Brian J. Lopresti, Christopher Janssen, Anita M. Trichel, Eliezer Masliah, Olivera J. Finn, Russell D. Salter, GEOFFREY H. MURDOCH, Chester A. Mathis, Clayton A. Wiley · 2012 · Journal of Neuroinflammation
  25. Imaging Biomarkers of Alzheimer Disease in Multiple Sclerosis
    Burcu Zeydan, Val J. Lowe, Ross R. Reichard, Scott A. Przybelski, Timothy G. Lesnick, Christopher G. Schwarz, Matthew L. Senjem, Jeffrey L. Gunter, Joseph E. Parisi, Mary M. Machulda et al. · 2020 · Annals of Neurology
  26. An unconventional hypothesis of oxidation in alzheimer's disease: intersections with excitotoxicity
    Steven W. Barger · 2004 · Frontiers in bioscience
  27. Immunotherapy for Alzheimer's disease and other dementias
    Delphine Boche, James A. R. Nicoll, Roy O. Weller · 2005 · Current Opinion in Neurology
  28. Vaccination Strategies for Alzheimer???s Disease
    Adele Woodhouse, Tracey C. Dickson, James Clement Vickers · 2007 · Drugs & Aging
  29. Methods to monitor monocytes-mediated amyloid-beta uptake and phagocytosis in the context of adjuvanted immunotherapies
    Maxime Hallé, Pascale Tribout-Jover, Anne-Marie Lanteigne, Jonathan Boulais, Julien R. St-Jean, Rachel Jodoin, Marie‐Pier Girouard, Florin Constantin, Annik Migneault, Frédéric Renaud et al. · 2015 · Journal of Immunological Methods
  30. Interplay Between Aging and Tau Pathology in Alzheimer’s Disease: Mechanisms and Translational Perspectives
    Mohammed Alrouji, Mohammed S. Alshammari, Tasqeeruddin Syed, Anas Shamsi · 2025 · Antioxidants
  31. Trajectory of brain-derived amyloid beta in Alzheimer’s disease: where is it coming from and where is it going?
    Ni Liu, Anaer Haziyihan, Wei Guang Zhao, Yu Chen, Hongbo Chao · 2024 · Translational Neurodegeneration
  32. Catalytic Immunoglobulin Gene Delivery in a Mouse Model of Alzheimer’s Disease: Prophylactic and Therapeutic Applications
    Jinghong Kou, Junling Yang, Jeong-Eun Lim, Abhinandan Pattanayak, Min Song, Stephanie A. Planque, Sudhir Paul, Ken-ichiro Fukuchi · 2014 · Molecular Neurobiology
  33. Limited Clearance of Pre-Existing Amyloid Plaques After Intracerebral Injection of Aβ Antibodies in Two Mouse Models of Alzheimer Disease
    Stina M. Fangmark Tucker, David Borchelt, Juan Carlos Troncoso · 2008 · Journal of Neuropathology & Experimental Neurology
  34. Therapeutic Potential of Neu1 in Alzheimer’s Disease Via the Immune System
    Aiza Khan, Sumit Kumar Das, Consolato Maria Sergi · 2021 · American Journal of Alzheimer s Disease & Other Dementias®
  35. Deglycosylated Anti-Aβ Antibody Dose–Response Effects on Pathology and Memory in APP Transgenic Mice
    Rachel Karlnoski, Arnon Rosenthal, Jennifer Alamed, Victoria Ronan, Marcia N. Gordon, Paul E. Gottschall, Jan Grimm, Jaume Pons, David Morgan · 2008 · Journal of Neuroimmune Pharmacology
  36. New insights into innate immunity in Alzheimer’s disease: From APOE protective variants to therapies
    Chen, Yun, Holtzman, David M. · 2024 · Trends in Immunology
  37. CCL3 correlates with the number of mood disturbances and personality changes in patients with Alzheimer's disease
    Anita Malgorzata Geppert, Jacek Losy, Elżbieta Przedpelska-Ober, Wojciech P. Kozubski · 2010 · Psychiatry Research
  38. Dynamic regulation of microglial functions by the non-steroidal anti-inflammatory drug NCX 2216: Implications for chronic treatments of neurodegenerative diseases
    Antonietta Bernardo, Laura Gasparini, Ennio Ongini, Luisa Minghetti · 2005 · Neurobiology of Disease
  39. B Lymphocytes in Alzheimer’s Disease—A Comprehensive Review
    Domenico Plantone, Matteo Pardini, Sara Locci, Flavio Mariano Nobili, Nicola De Stefano · 2022 · Journal of Alzheimer s Disease
  40. Engineered Antibodies to Improve Efficacy against Neurodegenerative Disorders
    Sarfaraz K. Niazi, Zamara Mariam, Matthias Magoola · 2024 · International Journal of Molecular Sciences
  41. Manipulation of microglial activity as a therapy for Alzheimer s disease
    Eng‐Ang Ling · 2012 · Frontiers in Bioscience-Scholar
  42. DNA Vaccine Therapy for Alzheimer's Disease: Present Status and Future Direction
    Yoshio Okura, Yoh Matsumoto · 2008 · Rejuvenation Research
  43. Amyloid-β Immunotherapies in Mice and Men
    Robert P. Brendza, David M. Holtzman · 2006 · Alzheimer Disease & Associated Disorders
  44. Antibody against C-terminal Abeta selectively elevates plasma Abeta
    Audrey J. Gray, Gaku Sakaguchi, Chiharu Shiratori, Amanda G. Becker, John J. LaFrancois, Paul S. S. Aisen, Karen Duff, Yasuji Matsuoka · 2007 · Neuroreport
  45. Early intervention anti-Aβ immunotherapy attenuates microglial activation without inducing exhaustion at residual plaques
    Lis de Weerd, Selina Hummel, Stephan A. Müller, Iñaki Paris, Thomas Sandmann, Marie Eichholtz, Robin Gröger, Amelie L. Englert, Stephan Wagner, Connie Ha et al. · 2025 · Molecular Neurodegeneration
  46. Mechanisms of ARIA: is it time to focus on the unique immune environment of the neurovascular unit?
    Kate E. Foley, Erica M. Weekman, Donna M. Wilcock · 2023 · Molecular Neurodegeneration
  47. Alzheimer's disease: is a vaccine possible?
    Rúbens Prince dos Santos Alves, Min Yang, Milene Tavares Batista, Luís Carlos de Souza Ferreira · 2014 · Brazilian Journal of Medical and Biological Research
  48. Vascular Considerations for Amyloid Immunotherapy
    Kate E. Foley, Donna M. Wilcock · 2022 · Current Neurology and Neuroscience Reports
  49. Targeting the amyloid-β antibody in the brain tissue of a mouse model of Alzheimer's disease
    Daniel McLean, Michael J. Cooke, Yuanfei Wang, Paul Fraser, Peter St George‐Hyslop, Molly Sandra Shoichet · 2011 · Journal of Controlled Release
  50. Approaches for Increasing Cerebral Efflux of Amyloid-β in Experimental Systems
    David A. Loeffler · 2024 · Journal of Alzheimer s Disease
  51. Intravenous Immunglobulin Binds Beta Amyloid and Modifies Its Aggregation, Neurotoxicity and Microglial Phagocytosis In Vitro
    Susann Cattepoel, Alexander Schaub, Miriam Ender, Annette Gaida, Alain Kropf, Ursula Guggisberg, Marc Wolfgang Nolte, Louis Fabri, Paul Anthony Adlard, David Isaac Finkelstein et al. · 2013 · PLoS ONE
  52. Contemporary perspectives in cerebral amyloid angiopathy
    Amina Sellimi, Julian Schwartze, Fiona Humphries, Larysa Panteleienko, Dermot Henry Mallon, Gargi Banerjee, David John Werring · 2025 · Expert Review of Neurotherapeutics
  53. Immunotherapy for Alzheimer's disease
    Weihua Wang, Liangfeng Fan, De-En Xu, Zhongmin Wen, Rong Yu, Quanhong Ma · 2012 · Acta Biochimica et Biophysica Sinica
  54. Beta Amyloid Peptides: Extracellular and Intracellular Mechanisms of Clearance in Alzheimer’s Disease
    Luis Fernando Hernández-Zimbrón, Elisa Gorostieta-Salas, Mei-Li Díaz-Hung, Roxanna Pérez-Garmendia, Gohar Gevorkian, Hugo Quiroz-Mercado · 2016 · InTech eBooks
  55. Four-dimensional microglia response to anti-Aβ treatment in APP/PS1xCX3CR1/GFP mice
    Mónica Garcı́a-Alloza, Laura A. Borrelli, Diana H. Thyssen, Suzanne E. Hickman, Joseph B. El Khoury, Brian J. Bacskai · 2013 · IntraVital
  56. In Vivo Electroporation of a New Gene Vaccine Encoding Ten Repeats of Aβ3-10 Prevents Brain Aβ Deposition and Delays Cognitive Impairment in Young Tg-APPswe/PSEN1dE9 Mice
    Sha Sha, Xiaona Xing, Wanshu Guo, Yu Li, Lixia Zong, Rong Guo, Yunpeng Cao · 2012 · Neurochemical Research
  57. Immunotherapy for Alzheimer's Disease and Other Dementias
    Delphine Boche, James A. R. Nicoll, Roy O. Weller · 2006 · Clinical Neuropharmacology
  58. Targeting phagocytosis for amyloid-β clearance: implications of morphology remodeling and microglia activation probed by bifunctional chimaeras
    Youqiao Wang, Zeyi Wang, Ziyi Liu, Jinyan Li, Shuo Yang, Yuxuan Zhao, Yangmei Huang, Chenyang Liao, Yiqiu Zhang, Jiaojiao Zhao et al. · 2025 · Nature Communications
  59. Sensory gamma entrainment: Impact on amyloid protein and therapeutic mechanism
    Jiaying Hu, Leyan Zheng, Ziyu Guan, Kexin Zhong, Fankai Huang, Qiankai Huang, Jing Yang, Weiyun Li, Shanshan Li · 2023 · Brain Research Bulletin
  60. Immune-Directed Gene Therapeutic Development for Alzheimer’s, Prion, and Parkinson’s Diseases
    Kathleen A. Maguire‐Zeiss, Howard J. Federoff · 2008 · Journal of Neuroimmune Pharmacology
  61. Evidence for Enhanced Efficacy of Passive Immunotherapy against Beta-Amyloid in CD33-Negative 5xFAD Mice
    Kathrin Gnoth, Stefanie Geißler, Julia Silvia Feldhaus, Nadine Taudte, Victoria Ilse, Sebastian Zürner, Sebastian Greiser, Ulf‐Dietrich Braumann, Jens‐Ulrich Rahfeld, Holger Cynis et al. · 2022 · Biomolecules
  62. The Role of the Immune System in Alzheimer's Disease
    Robert M. Cohen · 2009 · FOCUS The Journal of Lifelong Learning in Psychiatry
  63. Mouse models of Anti-Aβ immunotherapies
    Philip Pikus, Raymond Scott Turner, George William Rebeck · 2025 · Molecular Neurodegeneration
  64. Altered Clearance in Alzheimer's Disease and Cerebral Amyloid Angiopathy
    Soheil Mohammadi, Mahsa Dolatshahi, Farzaneh Rahmani, Cyrus A. Raji · 2025 · Neuroimaging Clinics of North America
  65. Structural biology of cell surface receptors implicated in Alzheimer’s disease
    Stefan J. Hermans, Tracy L. Nero, Craig J. Morton, Jonathan H. Gooi, Gabriela A. N. Crespi, Nancy C. Hancock, Chen Gao, Kenta Ishii, Jasmina Markulić, Michael W. Parker · 2021 · Biophysical Reviews
  66. Transgenic expression of β1 antibody in brain neurons impairs age-dependent amyloid deposition in APP23 mice
    Paolo Paganetti, Julia Reichwald, Dorothée Bleckmann, Dorothée Abramowski, Domenico Ammaturo, Carmen Barske, Simone Danner, Maurizio Molinari, Mathias M. Müller, Stéphanie Papin et al. · 2013 · Neurobiology of Aging
  67. Editorial: cytokine inhibition for treatment of Alzheimer's disease.
    Paul B. Rosenberg · 2006 · PubMed Central
  68. A Novel scFv Anti-Aβ Antibody Reduces Pathological Impairments in APP/PS1 Transgenic Mice via Modulation of Inflammatory Cytokines and Aβ-related Enzymes
    Meng-Ming Hu, Jun Zhang, Junting Yang, Yue Cao, Jin‐Shun Qi · 2018 · Journal of Molecular Neuroscience
  69. Monitoring the Cerebrospinal Fluid Cytokine Profile Using Membrane-Based Antibody Arrays
    Andrea González-Morales, Mercedes Lachén‐Montes, Joaquín Fernández‐Irigoyen, Enrique Santamaría · 2019 · Methods in molecular biology
  70. Positron emission tomography and single-photon emission computed tomography in central nervous system drug development
    David James Brooks · 2005 · Neurotherapeutics
  71. Advances in cellular and structural engineering of brain organoids for disease modeling: A Comprehensive Review
    Hyeongjoon Kim, Francis Joaquin Antonio Vasquez, Alvin Bacero Bello, Soo-Hong Lee · 2026 · Tissue and Cell
  72. Characteristics of infusion-related reactions to lecanemab in early Alzheimer’s disease: A multicenter real-world study in Northwestern China
    Peijie Liu, Jie Liu, Jia‐Yi Wang, Yong Du, Zhirong Liu, Heng Zhang, Aiqin Zhu, Gejuan Zhang, Xinling Meng, Chunmei Zhao et al. · 2026 · The Journal of Prevention of Alzheimer s Disease
  73. Blood-based therapies to combat neurodegenerative diseases
    Lee Jy, Mervyn Chen Xi Lim, Rhun Yian Koh, Min Tze Tsen, Soi Moi Chye · 2024 · Metabolic Brain Disease
  74. Established Beta Amyloid Pathology Is Unaffected by TREM2 Elevation in Reactive Microglia in an Alzheimer’s Disease Mouse Model
    Qiuju Yuan, Xiaodong Liu, Yi Zhang, Yan‐Fang Xian, Juntao Zou, Xie Zhang, Pengyun Huang, You‐Qiang Song, Zhi‐Xiu Lin · 2021 · Molecules
  75. Immunotherapeutic Approaches to Alzheimer’s Disease
    Josef Karkos · 2006 · Springer eBooks
  76. Chimeras co-targeting antigens and FcγRIIb trigger degradation of extracellular soluble proteins and pathological aggregates
    Mingjuan Du, Na Li, Tianqi Li, Zhuoqian Zhao, Huanzhen Liu, Xin Li, Nanxin Gong, Baoxin Duan, Wenli Wang, Jian Yi et al. · 2025 · Nature Communications
  77. From consortia discovery to biotech creation: An innovative approach to next‐gen Alzheimer's drugs
    Sarah F. Giardina, Alexander E. Culver, Chandrama Ahmed, Christian Mirescu, Adrian L. Oblak, Jared R. Brosch, Brent Clayton, Jeffrey L. Dage, Bruce T. Lamb, Timothy I. Richardson et al. · 2026 · Alzheimer s & Dementia
  78. The aggregation of amyloid-β: from condensation, nucleation, and conformation to targeting therapy
    Bangyao Chen, Tiancheng Chen, Zhendong Sun, Lulu Liu, Yu Jia, Yipin Ji, Jinlong Wang, Feifei Sun, Yunpeng Huang · 2026 · Life Sciences
  79. The contribution of inflammation to Alzheimer's disease in Down syndrome
    Alessandra Cadete Martini, Courtney M. Kloske, Donna M. Wilcock, Elizabeth Head · 2021 · Elsevier eBooks
  80. Beyond plaques and tangles: The role of immune cell dysfunction in Alzheimer's disease
    Nasif Hussain, Mohd Moin Khan, Ayushi Sharma, Rakesh Kumar Singh, Rizwan Hasan Khan · 2025 · Neurochemistry International
  81. Perspectives of Alzheimer's disease treatments
    John B. Davis, C. Bountra, Jill C. Richardson · 2008 · Handbook of clinical neurology
  82. Monitoring Cerebrospinal Fluid Inflammatory Mediators by Olink Target 48 Cytokine Panel
    Fabrício Zambom-Ferraresi, Fabíola Zambom-Ferraresi, Maite Izco-Cubero, Nicolás Martínez‐Velilla, Leire Extramiana, Joaquín Fernández‐Irigoyen, Enrique Santamaría, A. Llamas-Urbano, Y. Hanaee, Julio Manuel Martinez-Moreno et al. · 2025 · Methods in molecular biology
  83. Current status of Alzheimer’s disease immunotherapy and pharmacologic effect of BAN2401
    Shin Araki · 2010 · Folia Pharmacologica Japonica
  84. Brain Inflammation and the Neuronal Fate: from Neurogenesis to Neurodegeneration
    Maria Antonietta Ajmone‐Cat, Emanuele Cacci, Luisa Minghetti · 2009 · Oxford University Press eBooks
  85. The Rationale for an Immunological Approach to Alzheimer's Therapeutics
    David Morgan · 2007 · Springer eBooks
  86. Neuroinflammation in Alzheimer's disease: Characterization and modification of the response of transgenic mice to intrahippocampal lipopolysaccharide administration
    Donna L. Herber · 2004 · Digital Commons - University of South Florida (University of South Florida)
  87. Optimization of anti-Abeta antibody therapy
    Rachel Karlnoski · 2007 · Digital Commons - University of South Florida (University of South Florida)
  88. Approaches to Amyloid Therapies for the Treatment of Alzheimer's Disease
    Albert J. Robichaud, Ji‐In Kim, J. Steven Jacobsen · 2010 · Wiley eBooks
  89. Effects of Adoptive Transfer of Beta-Amyloid Sensitive Immune Cells in a Mouse Model for Alzheimer’s Disease
    Daniel C. Shippy · 2005 · Digital Commons - University of South Florida (University of South Florida)
  90. Implications of Human Umbilical Cord Blood Cells: An Immunotherapeutic Strategy for Alzheimer's Disease
    Donna Darlington · 2014 · Digital Commons - University of South Florida (University of South Florida)
  91. Amyloid-β Protofibrils in Alzheimer´s Disease : Focus on Antibodies, Inflammation and Astrocytes
    Sofia Söllvander · 2015 · KTH Publication Database DiVA (KTH Royal Institute of Technology)
  92. Immunotherapeutic Approaches Against Amyloid-β in Drug Discovery for Alzheimer’s Disease
    Seung‐Hoon Yang, Jiyoon Kim, Young Soo Kim · 2015 · Springer eBooks
  93. Active and Passive Immunotherapy Against Tau: Effects and Potential Mechanisms
    Kiran Yanamandra, Marc I. Diamond, David M. Holtzman · 2016 · Methods in pharmacology and toxicology
  94. Literaturverzeichnis
    2007 · Steinkopff eBooks
  95. Anti-Aβ immunotherapy-mediated amyloid clearance attenuates microglial activation without inducing exhaustion at residual plaques
    Lis de Weerd, Selina Hummel, Stephan A. Müller, Iñaki Paris, Thomas Sandmann, Marie Eichholtz, Robin Gröger, Amelie L. Englert, Stephan Wagner, Connie Ha et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  96. CNS-11g reduces α-synuclein pathology and restores motor function in a Parkinson’s model
    Sally Ann Frautschy, Kapil Manglani, Xiaohong Zuo, Cansheng Zhu, Mychica R. Jones, Alex Bombino, Hope Pan, Ke Hou, J.M. Kwon, Bruce Teter et al. · 2025 · Research Square
  97. Recent advances in symptomatic management and immunotherapies for Alzheimer's disease treatment: a narrative review
    Sarah Hyunsoh Park, Jihoon Suh, Jee Hoon Roh · 2025 · Journal of Korean Medical Association
  98. Increased CD33 levels tune activation and function of induced human microglial cells through inhibition of the TREM2 pathway
    Amr Omer, Smita Jagtap, Elga Morrison, Lauren M. Carito, Alexander Lee Prinzen, Stefan I. McDonough, Benjamin J. Andreone · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  99. Intervention of ginseng-derived macromolecular drugs in Alzheimer’s disease: exploring mechanisms and assessing potential
    Weiqiao Liu, Yunfan Bai, Wenyi Qu, Xiaoying Zhang, Shuo Zhou, Haoming Luo, Ming Zhu, Dongyang Li, Xiaoxue Fang · 2026 · Frontiers in Aging Neuroscience
  100. Cerebellar cortical amyloid deposition biases 18F-Florbetapir PET quantification with whole cerebellum as reference region
    Meixi Wang, Sheng Bi, Hanxiao Xue, Le Guan, Yan Wang, Xuemei Zhang, Xiaocao Liu, Xiaoyin Xu, Chun Zhang, Zhigang Qi et al. · 2026 · European Journal of Nuclear Medicine and Molecular Imaging